Strides Pharma Science Ltd Q1 FY2024-25 net profit rises to Rs. 70.20 crores

Strides Pharma Science Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 1100.221 crores during the period ended June 30, 2024 as compared to Rs. 1070.489 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 70.202 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 18.175 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 7.62 for the period ended June 30, 2024 as compared to Rs. 1.97 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 1100.221 crs	₹1070.489 crs	2.78%
Net Profit	₹70.202 crs	₹18.175 crs	286.26%
EPS	₹7.62	₹1.97	286.80%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 1100.221 crores during the period ended June 30, 2024 as compared to Rs.938.639 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.70.202 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.-7.113 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.7.62 for the period ended June 30, 2024 as compared to Rs.-0.79 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 1100.221 crs	₹938.639 crs	17.21%
Net Profit	₹70.202 crs	₹-7.113 crs	1,086.95%
EPS	₹7.62	₹-0.79	1,064.56%

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 1033.75 as compared to the previous close of Rs. 1022.00. The total number of shares traded during the day was 80922 in over 7206 trades.

The stock hit an intraday high of Rs. 1080.00 and intraday low of 994.25. The net turnover during the day was Rs. 84386868.00.

Source : Equity Bulls

Keywords

StridesPharmaScience Q1FY25 FY2025 Q1FY2025 ResultUpdate